DSM-III

DSM-III
source
Name	DSM-III
Caption	Third edition of the Diagnostic and Statistical Manual of Mental Disorders
Author	American Psychiatric Association
Country	United States
Language	English
Subject	Classification of mental disorders
Publisher	American Psychiatric Association
Pub date	1980
Pages	494
Preceded by	DSM-II
Followed by	DSM-III-R

DSM-III was the third edition of the Diagnostic and Statistical Manual of Mental Disorders published in 1980 by the American Psychiatric Association. It represented a paradigmatic shift in psychiatric nosology with operationalized criteria, multiaxial assessment, and an emphasis on reliability that influenced clinical practice, research, and policy across institutions such as National Institute of Mental Health, Veterans Health Administration, and World Health Organization programs. The manual’s development involved figures from academic centers including Harvard Medical School, Johns Hopkins University, and Columbia University, and intersected with controversies connected to public figures and movements such as Thomas Szasz, R.D. Laing, and advocacy by National Alliance on Mental Illness.

History and development

The project that produced DSM-III grew from initiatives at the American Psychiatric Association after critiques of the DSM-II and reports from institutions like the National Institute of Mental Health and the World Health Organization's work on the International Classification of Diseases. Leadership included academics affiliated with Washington University in St. Louis, University of Pennsylvania, Yale School of Medicine, and University of California, Los Angeles; consultants included clinicians linked to Massachusetts General Hospital, McLean Hospital, and Mount Sinai Hospital. Influential contributors had connections with researchers such as Elliot S. Valenstein, Robert Spitzer, Aubertin L., and colleagues from Columbia University College of Physicians and Surgeons who drew on field trials at centers like Bellevue Hospital and St. Elizabeths Hospital. The development process engaged funding and policy conversations involving National Institutes of Health, Department of Health and Human Services, and legislative oversight from bodies including United States Congress committees. The manual’s release followed debates that involved scholars from Oxford University, Cambridge University, University of Toronto, and clinicians practicing in settings such as Mayo Clinic and Cleveland Clinic.

Diagnostic criteria and structure

DSM-III introduced operationalized, behaviorally anchored diagnostic criteria influenced by researchers at Bell Telephone Laboratories-sponsored conferences and methodologists trained at Columbia University and University College London. The manual organized disorders using descriptive checklists developed from field studies conducted at sites like Stanford University Medical Center, University of Michigan, and University of Pittsburgh Medical Center. It implemented a multiaxial system reflecting clinical and social dimensions recognized by programs at National Institute of Mental Health, Veterans Affairs Medical Centers, and community clinics linked to Mental Health America. Categories included mood disorders, psychotic disorders, anxiety disorders, somatoform disorders, and personality disorders, structured in ways that influenced diagnostic research at institutions such as King's College London, University of Sydney, University of Melbourne, and Karolinska Institute. The manual’s diagnostic algorithms were intended to improve interrater reliability in settings from Bellevue Hospital emergency services to outpatient clinics at Johns Hopkins Hospital.

Impact on psychiatry and clinical practice

DSM-III markedly affected training at medical schools like Harvard Medical School, Perelman School of Medicine at the University of Pennsylvania, and Icahn School of Medicine at Mount Sinai, and altered curricula in residency programs at Massachusetts General Hospital, Bellevue Hospital Center, and UCLA Medical Center. It shaped reimbursement and administrative policies used by insurers such as Blue Cross Blue Shield and influenced coding practices aligned with editions of the International Classification of Diseases promulgated by World Health Organization. Research funding priorities at National Institute of Mental Health and foundations like Robert Wood Johnson Foundation shifted toward studies using DSM-III constructs, affecting work at research centers including Salk Institute, National Institutes of Health Clinical Center, and Scripps Research. Judicial and forensic practice referenced DSM-III criteria in cases adjudicated in courts such as the United States Supreme Court, federal district courts, and state supreme courts, and it influenced institutional protocols at Rikers Island, state psychiatric hospitals, and correctional health services. The manual also informed public-health programs run by Centers for Disease Control and Prevention and policy debates in legislatures from United States Congress committees to state legislatures.

Controversies and criticisms

From its inception DSM-III provoked critiques from scholars and activists including Thomas Szasz, R.D. Laing, and advocates associated with National Alliance on Mental Illness and Mental Health America. Critics argued about medicalization raised in writings by Michel Foucault, contested validity in exchanges with researchers at Maudsley Hospital, and debated reliability-versus-validity tensions raised by investigators at Johns Hopkins University and Yale University. Debates over categories such as homosexuality, which intersected with activism from groups like Gay Liberation Front and professional changes endorsed by the American Psychiatric Association earlier in 1973, continued in public forums involving scholars from Rutgers University and University of California, Berkeley. Questions about pharmaceutical influence involved companies including Eli Lilly and Company, Pfizer, and GlaxoSmithKline, and led to scrutiny by policy analysts at Congressional Research Service and watchdogs such as Public Citizen. Legal scholars at Harvard Law School and Columbia Law School analyzed DSM-III’s role in competency and insanity defenses, while anthropologists at University of Chicago and Oxford University critiqued its cross-cultural applicability.

Revisions and legacy

DSM-III’s methodological innovations prompted rapid revision, producing DSM-III-R and later editions that continued operationalization efforts in DSM-IV and DSM-5. Its legacy is evident in clinical manuals, textbooks published by houses like Wiley-Blackwell and Springer, and training materials used at institutions including American Board of Psychiatry and Neurology certification programs. The manual influenced longitudinal cohort studies such as the Epidemiologic Catchment Area Study and the National Comorbidity Survey, and its taxonomy continues to inform debates in journals like The Lancet, Journal of the American Medical Association, and American Journal of Psychiatry. Archival collections related to the manual are held at repositories including National Library of Medicine, Library of Congress, and university archives at Columbia University and Yale University.

International influence and adoption

Although produced by the American Psychiatric Association, DSM-III affected diagnostic practice worldwide through collaborations with the World Health Organization, training programs at World Psychiatric Association conferences, and adoption in clinical settings from NHS (England) hospitals to clinics in Canada, Australia, Japan, India, and South Africa. Translations and comparative studies involved researchers at University of Tokyo, Peking University, University of Cape Town, and University of São Paulo, and influenced harmonization efforts with the International Classification of Diseases used by World Health Organization. Debates about cultural validity engaged scholars from Anthropology Department, University of Chicago, SOAS University of London, and University of Nairobi, while international policy discussions occurred at forums such as meetings of the United Nations and conferences sponsored by World Health Organization.

Category:Psychiatry